These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32274701)

  • 21. Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies.
    Horbinski C; Kelly L; Nikiforov YE; Durso MB; Nikiforova MN
    J Mol Diagn; 2010 Jul; 12(4):487-92. PubMed ID: 20431032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.
    Pope WB; Prins RM; Albert Thomas M; Nagarajan R; Yen KE; Bittinger MA; Salamon N; Chou AP; Yong WH; Soto H; Wilson N; Driggers E; Jang HG; Su SM; Schenkein DP; Lai A; Cloughesy TF; Kornblum HI; Wu H; Fantin VR; Liau LM
    J Neurooncol; 2012 Mar; 107(1):197-205. PubMed ID: 22015945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of a highly sensitive digital PCR assay to detect a small fraction of IDH1 R132H-mutant alleles in diffuse gliomas.
    Satomi K; Yoshida A; Matsushita Y; Sugino H; Fujimoto K; Honda-Kitahara M; Takahashi M; Ohno M; Miyakita Y; Narita Y; Yatabe Y; Shibahara J; Ichimura K
    Brain Tumor Pathol; 2022 Oct; 39(4):210-217. PubMed ID: 35902443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.
    Jabbar KJ; Luthra R; Patel KP; Singh RR; Goswami R; Aldape KD; Medeiros LJ; Routbort MJ
    Am J Surg Pathol; 2015 Apr; 39(4):454-61. PubMed ID: 25634750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IDH1 mutation detection by droplet digital PCR in glioma.
    Wang J; Zhao YY; Li JF; Guo CC; Chen FR; Su HK; Zhao HF; Long YK; Shao JY; To Ss; Chen ZP
    Oncotarget; 2015 Nov; 6(37):39651-60. PubMed ID: 26485760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IDH1 mutations in oligodendroglial tumors: comparative analysis of direct sequencing, pyrosequencing, immunohistochemistry, nested PCR and PNA-mediated clamping PCR.
    Lee D; Suh YL; Kang SY; Park TI; Jeong JY; Kim SH
    Brain Pathol; 2013 May; 23(3):285-93. PubMed ID: 23072665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pyrosequencing-based assay for the rapid detection of IDH1 mutations in clinical samples.
    Setty P; Hammes J; Rothämel T; Vladimirova V; Kramm CM; Pietsch T; Waha A
    J Mol Diagn; 2010 Nov; 12(6):750-6. PubMed ID: 20847279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms.
    Kurt H; Bueso-Ramos CE; Khoury JD; Routbort MJ; Kanagal-Shamanna R; Patel UV; Jorgensen JL; Wang SA; Ravandi F; DiNardo C; Luthra R; Medeiros LJ; Patel KP
    Am J Surg Pathol; 2018 May; 42(5):569-577. PubMed ID: 29635257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid detection of isocitrate dehydrogenase 1 mutation status in glioma based on Crispr-Cas12a.
    Feng Z; Kong D; Jin W; He K; Zhao J; Liu B; Xu H; Yu X; Feng S
    Sci Rep; 2023 Apr; 13(1):5748. PubMed ID: 37029174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain Reaction.
    Gondim DD; Gener MA; Curless KL; Cohen-Gadol AA; Hattab EM; Cheng L
    Appl Immunohistochem Mol Morphol; 2019; 27(10):722-725. PubMed ID: 30358614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples.
    Solomon JP; Munoz-Zuluaga C; Slocum C; Dillard A; Cong L; Wang J; Lindeman N; Kluk M; Liechty B; Pisapia D; Rennert H; Velu PD
    Diagn Pathol; 2024 May; 19(1):70. PubMed ID: 38796421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic testing for IDH1 and IDH2 variants in acute myeloid leukemia an algorithmic approach using high-resolution melting curve analysis.
    Patel KP; Barkoh BA; Chen Z; Ma D; Reddy N; Medeiros LJ; Luthra R
    J Mol Diagn; 2011 Nov; 13(6):678-86. PubMed ID: 21889610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COLD PCR HRM: a highly sensitive detection method for IDH1 mutations.
    Boisselier B; Marie Y; Labussière M; Ciccarino P; Desestret V; Wang X; Capelle L; Delattre JY; Sanson M
    Hum Mutat; 2010 Dec; 31(12):1360-5. PubMed ID: 20886613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas.
    Takano S; Kato Y; Yamamoto T; Liu X; Ishikawa E; Kaneko MK; Ogasawara S; Matsuda M; Noguchi M; Matsumura A
    Brain Tumor Pathol; 2015 Jul; 32(3):169-75. PubMed ID: 25652153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
    Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
    Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of BCAT1 Expression is a Sensitive Marker for IDH-Mutant Diffuse Glioma.
    Chen YY; Ho HL; Lin SC; Hsu CY; Ho DM
    Neurosurgery; 2019 Sep; 85(3):335-342. PubMed ID: 30113684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of IDH1 Mutation in cfDNA and Tissue of Adult Diffuse Glioma with Allele-Specific qPCR.
    Husain A; Mishra S; Siddiqui MH; Husain N
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):961-968. PubMed ID: 36974551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
    Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
    Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
    Preusser M; Wöhrer A; Stary S; Höftberger R; Streubel B; Hainfellner JA
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):715-23. PubMed ID: 21760534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of high-resolution melting analysis with direct sequencing for the detection of recurrent mutations in DNA methyltransferase 3A and isocitrate dehydrogenase 1 and 2 genes in acute myeloid leukemia patients.
    Gorniak P; Ejduk A; Borg K; Makuch-Lasica H; Nowak G; Lech-Maranda E; Prochorec-Sobieszek M; Warzocha K; Juszczynski P
    Eur J Haematol; 2016 Feb; 96(2):181-7. PubMed ID: 25891904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.